Nu Skin Enterprises, Inc.  

(Public, NYSE:NUS)   Watch this stock  
Find more results for NUS
+0.12 (0.36%)
Feb 5 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 33.27 - 34.25
52 week 29.52 - 62.87
Open 33.39
Vol / Avg. 1.23M/1.00M
Mkt cap 1.94B
P/E 14.08
Div/yield 0.35/4.15
EPS 2.40
Shares 57.23M
Beta 1.37
Inst. own 80%
Feb 11, 2016
Q4 2015 NU Skin Enterprises Inc Earnings Call - 5:00PM EST - Add to calendar
Feb 11, 2016
Q4 2015 NU Skin Enterprises Inc Earnings Release - 4:00PM EST - Add to calendar
Jan 13, 2016
NU Skin Enterprises Inc at ICR Conference
Dec 4, 2015
Nu Skin's 2015 Annual Investor Day - Webcast
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin 2.85% 7.36%
Operating margin 7.45% 13.71%
EBITD margin - 15.84%
Return on average assets 4.13% 11.01%
Return on average equity 7.40% 21.01%
Employees 5,000 -
CDP Score - -


75 W Center St
PROVO, UT 84601-4432
United States - Map
+1-801-3451000 (Phone)
+1-801-3455999 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Nu Skin Enterprises, Inc. is a global direct selling company marketing personal care and nutritional products in 53 markets worldwide. The Company develops and distributes anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands, respectively. The Company has Pharmanex nutritional supplements and Nu Skin personal care products under its age LOC anti-aging brand. The Company offers anti-aging personal care products. Products in this category include its ageLOC Galvanic Spa System, its ageLOC Galvanic Body Spa, ageLOC Galvanic Spa Body Shaping Gel and ageLOC Dermatic Effects Body Contouring Lotion and its ageLOC Transformation anti-aging skin care system. The Company markets a variety of products under its Pharmanex brand. LifePak, its line of micronutrient supplements. Other anti-aging nutritional supplements include its ageLOC R2, which is designed to renew and recharge the body.

Officers and directors

Steven J. Lund Executive Chairman of the Board
Age: 61
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
M. Truman Hunt President, Chief Executive Officer, Director
Age: 56
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Ritch N. Wood Chief Financial Officer
Age: 49
Bio & Compensation  - Reuters
Ryan S Napierski President - Global Sales and Operations
Age: 41
Bio & Compensation  - Reuters
Scott E. Schwerdt President - Americas Region
Age: 57
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Joseph Y. Chang Ph.D. Executive Vice President - Product Development, Chief Scientific Officer
Age: 62
Bio & Compensation  - Reuters
D. Matthew Dorny General Counsel, Secretary
Age: 50
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Daniel W. Campbell Lead Independent Director
Age: 60
Bio & Compensation  - Reuters
Nevin N. Andersen Independent Director
Age: 74
Bio & Compensation  - Reuters
Andrew D. Lipman Independent Director
Age: 63
Bio & Compensation  - Reuters